Product Details for ANDA 090432
ESCITALOPRAM OXALATE (ESCITALOPRAM OXALATE)
EQ 5MG BASE
Marketing Status: Prescription
EQ 10MG BASE
Marketing Status: Prescription
EQ 20MG BASE
Marketing Status: Prescription
EQ 5MG BASE
Marketing Status: Prescription
Active Ingredient: ESCITALOPRAM OXALATE
Proprietary Name: ESCITALOPRAM OXALATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 5MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A090432
Product Number: 001
Approval Date: Sep 11, 2012
Applicant Holder Full Name: AUROBINDO PHARMA LTD
Marketing Status: Prescription
Patent and Exclusivity Information
ESCITALOPRAM OXALATE (ESCITALOPRAM OXALATE)
Proprietary Name: ESCITALOPRAM OXALATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 5MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A090432
Product Number: 001
Approval Date: Sep 11, 2012
Applicant Holder Full Name: AUROBINDO PHARMA LTD
Marketing Status: Prescription
Patent and Exclusivity Information
EQ 10MG BASE
Marketing Status: Prescription
Active Ingredient: ESCITALOPRAM OXALATE
Proprietary Name: ESCITALOPRAM OXALATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 10MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A090432
Product Number: 002
Approval Date: Sep 11, 2012
Applicant Holder Full Name: AUROBINDO PHARMA LTD
Marketing Status: Prescription
Patent and Exclusivity Information
ESCITALOPRAM OXALATE (ESCITALOPRAM OXALATE)
Proprietary Name: ESCITALOPRAM OXALATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 10MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A090432
Product Number: 002
Approval Date: Sep 11, 2012
Applicant Holder Full Name: AUROBINDO PHARMA LTD
Marketing Status: Prescription
Patent and Exclusivity Information
EQ 20MG BASE
Marketing Status: Prescription
Active Ingredient: ESCITALOPRAM OXALATE
Proprietary Name: ESCITALOPRAM OXALATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 20MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A090432
Product Number: 003
Approval Date: Sep 11, 2012
Applicant Holder Full Name: AUROBINDO PHARMA LTD
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: ESCITALOPRAM OXALATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 20MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A090432
Product Number: 003
Approval Date: Sep 11, 2012
Applicant Holder Full Name: AUROBINDO PHARMA LTD
Marketing Status: Prescription
Patent and Exclusivity Information